From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 83 (1-3), 59-65
- https://doi.org/10.1016/s1472-9792(02)00078-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Increasing transparency in partnerships for health – introducing the Green Light CommitteeTropical Medicine & International Health, 2002
- Methodological Problems in the Molecular Epidemiology of TuberculosisAmerican Journal of Epidemiology, 2002
- Responding to Market Failures in Tuberculosis ControlScience, 2001
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000
- First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisonsThe Lancet, 1999
- Influence of Sampling on Estimates of Clustering and Recent Transmission of Mycobacterium tuberculosis Derived from DNA Fingerprinting TechniquesAmerican Journal of Epidemiology, 1999
- Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus"BMJ, 1998
- A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomesPublished by American Medical Association (AMA) ,1996
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995
- Community-based Short-Course Treatment of Pulmonary Tuberculosis in a Developing Nation: Initial Report of an Eight-Month, Largely Intermittent Regimen in a Population with a High Prevalence of Drug ResistanceAmerican Review of Respiratory Disease, 1990